Invention Grant
US09227946B2 1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment 有权
1- [2-(2,4-二甲基苯基硫烷基) - 苯基]哌嗪作为具有组合的5-羟色胺再摄取的化合物,用于治疗认知障碍的5-HT3和5-HT1a活性

  • Patent Title: 1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment
  • Patent Title (中): 1- [2-(2,4-二甲基苯基硫烷基) - 苯基]哌嗪作为具有组合的5-羟色胺再摄取的化合物,用于治疗认知障碍的5-HT3和5-HT1a活性
  • Application No.: US14242337
    Application Date: 2014-04-01
  • Publication No.: US09227946B2
    Publication Date: 2016-01-05
  • Inventor: Andre FaldtRene HolmHeidi Lopez de Diego
  • Applicant: H. Lundbeck A/S
  • Applicant Address: DK Copenhagen-Valby
  • Assignee: H. Lundbeck A/S
  • Current Assignee: H. Lundbeck A/S
  • Current Assignee Address: DK Copenhagen-Valby
  • Agency: Fish & Richardson P.C.
  • Priority: DK200600824 20060616; DK200601223 20060922; DK200601384 20061025; DK200700427 20070320
  • Main IPC: A61K31/495
  • IPC: A61K31/495 C07D295/096 A61K9/14
1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment
Abstract:
1-[2-(2,4-dimethylphenylsulphanyl)phenyl]piperazine exhibits potent activity on SERT, 5-HT3 and 5-HT1A and may as such be useful for the treatment of cognitive impairment, especially in depressed patients.
Information query
Patent Agency Ranking
0/0